CDC45通过影响细胞周期来促进肺腺癌的干部和转移
Yafeng Liu1,2, Tao Han1,2, Zhi Xu1
1School of Medicine, Anhui University of Science and Technology, Chongren Building, No 168, Taifeng St, Huainan, 232001, People's Republic of China.
Journal of translational medicine
|April 8, 2024
概括
细胞分裂周期蛋白45 (CDC45) 被确定为非小细胞肺癌 (NSCLC) 的关键调节剂. 它的击倒抑制了癌细胞的增殖,迁移和瘤生长,这表明CDC45是潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是全球癌症相关死亡的主要原因.
- 了解驱动NSCLC干细胞和转移的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究细胞分裂周期蛋白45 (CDC45) 在NSCLC中的作用.
- 为了确定CDC45对癌症干部和转移的影响.
- 评估CDC45作为NSCLC的潜在治疗点.
主要方法:
- 差异基因表达分析和LASSO回归以确定关键基因.
- 在体外测试 (殖民地形成,,Transwell) 以评估在CDC45敲击后的繁殖和迁移.
- 西方涂抹分析蛋白质表达和细胞循环调节.
- 在体内小鼠模型中评估瘤生长抑制.
主要成果:
- CDC45被确定为与NSCLC干细胞和淋巴结转移相关的关键基因.
- CDC45 knockdown显著抑制了肺癌细胞的扩散和迁移.
- CDC45 knockdown导致G2/M阶段的细胞循环停止,并且与干性标记物负相关.
- 在体内研究证实,CDC45敲击抑制了瘤生长.
结论:
- 在NSCLC中,CDC45作为干细胞,增殖,迁移和细胞循环的新型调节剂.
- CDC45是NSCLC治疗中一个有前途的治疗点.
- 对CDC45的机制的进一步研究可以指导未来的治疗策略.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


